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Abstract
Background: Single-guide RNA (sgRNA) is one of the two key components of the clustered regularly interspaced
short palindromic repeats (CRISPR)-Cas9 genome-editing system. The current commonly used sgRNA structure has
a shortened duplex compared with the native bacterial CRISPR RNA (crRNA)–transactivating crRNA (tracrRNA)
duplex and contains a continuous sequence of thymines, which is the pause signal for RNA polymerase III and
thus could potentially reduce transcription efficiency.
Results: Here, we systematically investigate the effect of these two elements on knockout efficiency and showed
that modifying the sgRNA structure by extending the duplex length and mutating the fourth thymine of the
continuous sequence of thymines to cytosine or guanine significantly, and sometimes dramatically, improves
knockout efficiency in cells. In addition, the optimized sgRNA structure also significantly increases the efficiency
of more challenging genome-editing procedures, such as gene deletion, which is important for inducing a loss
of function in non-coding genes.
Conclusions: By a systematic investigation of sgRNA structure we find that extending the duplex by approximately
5 bp combined with mutating the continuous sequence of thymines at position 4 to cytosine or guanine
significantly increases gene knockout efficiency in CRISPR-Cas9-based genome editing experiments.
Background
The clustered regularly interspaced short palindromic re-
peats (CRISPR) system has recently been developed into a
powerful genome-editing technology [1–6]. This system is
composed of two components: the nuclease Cas9 and the
guide RNA. After maturation, the native type-II CRISPR
guide RNA is composed of a 42-nucleotide CRISPR RNA
(crRNA) and an 89-nucleotide transactivating crRNA
(tracrRNA) [6] (Figure S1a in Additional file 1). Jinek et al.
[6] systematically studied the minimal sequence require-
ment of the guide RNA in vitro and linked two minimal se-
quences together to create the short-version single-guide
RNA (sgRNA; +48 nucleotides; Figure S1b in Additional
file 1). However, a longer version of the sgRNA (+85 nucle-
otides), which is 37 nucleotides longer at the 5’ end (Figure
S1c in Additional file 1), was shown to be much more effi-
cient [7–9] and is now commonly used. This commonly
used sgRNA has a shortened duplex compared with the
native guide RNA (Figure S1a, c in Additional file 1). In
addition, there is a continuous sequence of Ts, which is the
pause signal for RNA polymerase III; this signal could po-
tentially reduce transcription efficiency and knockout effi-
ciency. Hsu et al. [9] showed that changing these two
elements did not have a significant effect on knockout effi-
ciency and concluded that the sgRNA (+85 nucleotides)
without mutations and duplex extension is the most active
sgRNA architecture. However, Chen et al. [10] reported
that sgRNAs with a mutated continuous sequence of Ts
and extended duplex significantly enhance the imaging ef-
ficiency of a dCas9 (a mutated version of Cas9 lacking
nickase activity)–green fluorescent protein (GFP) fusion
protein in cells, suggesting that changing these two ele-
ments enhances dCas9 binding to target sites and might
also increase the knockout efficiency of Cas9. In this study,
we systematically investigated the effect of changing these
two elements on knockout efficiency and found that, over-
all, extending the duplex and mutating the continuous se-
quence of Ts significantly improved knockout efficiency.* Correspondence: haoquan.wu@ttuhsc.edu
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Results
The current most commonly used sgRNA design has
the duplex shortened by 10 bp compared with the na-
tive crRNA–tracrRNA duplex (Fig. 1a), which does not
seem to reduce its functionality in vitro [6]. Hsu et al.
[9] also showed that extending the duplex appeared to
have no effect on knockout efficiency in cells. However,
Chen et al. [10] showed that extending the duplex signifi-
cantly enhances imaging efficiency of the dCas9–GFP fu-
sion protein in cells. We suspected that extending the
duplex might increase knockout efficiency in cells. To test
this hypothesis, we extended the duplex in two sgRNAs
targeting the CCR5 gene, as shown in Fig. 1a, and deter-
mined the knockout efficiency of these mutants in TZM-
bl cells. Extending the duplex by 1, 3, 5, 8, or 10 bp signifi-
cantly increased the knockout efficiency in both sgRNAs
tested, and extending the duplex by 5 bp appeared to yield
the highest efficiency at the protein level (Fig. 1b; Figure
S2 in Additional file 1). The modification rate at the DNA
level was also confirmed by deep sequencing of target sites
(Additional file 2), and the results correlated well with the
results determined at the protein level (Fig. 1b; Figure S2
in Additional file 1). Since measuring the modification
rate by deep sequencing is more expensive and labor
intensive, we mainly relied on fluorescence-activated
cell sorting (FACS) to determine the CCR5 disruption
rate in this study. When the effect of extending the du-
plex was tested for another sgRNA (sp2), the results
Fig. 1 Knockout efficiency can be increased by extending the duplex and disrupting the continuous sequence of Ts. a The duplex extension.
Green indicates the 3’ 34 nucleotides, which are not required for sgRNA functionality in vitro but are required in cells; red indicates the extended
base pairs. b Extension of the duplex increased knockout efficiency. Constructs harboring sgRNAs targeting the CCR5 gene were co-transfected
with a Cas9-expressing plasmid into TZM-bl cells. An sgRNA targeting the HIV genome served as mock control. The GFP-positive cells were sorted
out 48 hours after transfection, and the gene modification rates were determined at the protein and DNA levels, respectively. Protein level disruption:
the expression of CCR5 was determined by flow cytometry analysis. The raw data are shown in Figure S2 in Additional file 1. DNA level modification
rate: the genomic DNA was extracted, and the target sites were amplified and deep-sequenced with a MiSeq sequencer. The raw data are provided in
Additional file 2. c The experiment in (b) at the protein level was repeated for another sgRNA, sp2. The difference with (b) is that the cells were not
sorted, but the CCR5 disruption rate was measured in GFP-positive cells. The raw data are shown in Figure S2 in Additional file 1. d Mutation of the
RNA polymerase (Pol III) pause signal significantly increased knockout efficiency. The mutated nucleotides are shown in bold. The raw data are shown
in Figure S3 in Additional file 1. The graphs represent biological repeats from one of three independent experiments with similar results, shown as
mean ± standard deviation (n= 3). Significance was calculated using Student's t-test: *P< 0.05; **P< 0.01; ***P< 0.005; ****P < 0.001. O original, M mutant
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were consistent with those for sp1 (Fig. 1c; Figure S2 in
Additional file 1). Thus, extending the duplex appears
to increase the knockout efficiency of the CRISPR-Cas9
system.
Because the continuous sequence of Ts after the guide
sequence is the pause signal for RNA polymerase III [11],
the effect of its disruption in sgRNAs has been previously
studied [9, 10]. We suspected that mutating the continu-
ous sequence of Ts might also improve knockout effi-
ciency in cells. Accordingly, we mutated this sequence at
different positions and determined the knockout efficiency
of the mutants (Fig. 1d; Figure S3 in Additional file 1).
The knockout efficiency was increased in all mutants, and
the mutation at position 4 had the greatest effect.
Next, we systematically investigated the effect of extend-
ing the duplex while mutating the fourth T in the se-
quence of Ts (Fig. 2a; Figure S4 in Additional file 1).
Consistent with the result shown in Fig. 1b, mutating the
fourth T increased the knockout efficiency significantly for
all four sgRNAs tested (Fig. 2a). On top of the increase
due to mutation, extending the duplex also increased the
knockout efficiency, reaching a peak at around 5 bp but
then declining with longer extensions, although the
pattern appears to be slightly different for different
sgRNAs (Fig. 2a), which is consistent with Chen et al.’s
results showing that modifying both elements signifi-
cantly enhances the imaging efficiency of a dCas9–GFP
fusion protein in cells [10].
We previously tested the effect of mutating T→A on
knockout efficiency without extending the duplex (Fig. 1c).
Next, we also wanted to test the effect of mutating T→A,
C, or G while also extending the duplex. Consistent with
previous observations, mutations at position 4 generally
had the highest knockout efficiency, although mutating
T→C at position 1 had a similar effectiveness. In addition,
mutating T→C or G generally had higher knockout effi-
ciency than mutating T→A at various positions (Fig. 2b;
Figure S5 in Additional file 1). Thus, mutating T→C or G
at position 4 yielded the highest knockout efficiency.
Based on these results, mutating T→G or C at pos-
ition 4 and extending the duplex by ~5 bp appears to
achieve the optimal sgRNA structure, with the highest
Fig. 2 Knockout efficiency can be further increased by combining duplex extension with disruption of the continuous sequence of Ts. a The
effect of duplex extension when mutating the fourth T to an A in four sgRNAs. The raw data are shown in Figure S4 in Additional file 1. b The
effect of mutation of Ts at the indicated positions to A, C, or G when also extending the duplex by 5 bp. The raw data are shown in Figure S5 in
Additional file 1. The graphs represent biological repeats from one of three independent experiments with similar results, shown as mean ± standard
deviation (n= 3). Significance was calculated using Student's t-test: *P< 0.05; **P< 0.01; ***P< 0.005; ****P< 0.001. M mutant
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knockout efficiency. Therefore, we compared the knock-
out efficiency of the original and optimized structures
for 16 sgRNAs targeting CCR5. A typical optimized
structure had a T→G mutation at position 4 and ex-
tended the duplex by 5 bp. In 15 out of 16 sgRNAs, the
optimized structure increased the knockout efficiency
significantly and for sp10, 14, 15, 17, and 18 did so dra-
matically (Fig. 3a; Figure S6 in Additional file 1).
To exclude the possibility that the increase in
knockout efficiency using the optimized sgRNA struc-
ture is limited to TZM-bl cells or the CCR5 gene, we
also tested eight sgRNAs targeting the CD4 gene in
Jurkat cells. Consistent with the results observed in
TZM-bl cells for the CCR5 gene, the optimized sgRNA
design also significantly increased the efficiency of
knocking out the CD4 gene in the Jurkat cell line
(Fig. 3b; Figure S7 in Additional file 1). Thus, the opti-
mized sgRNA structure appears to generally increase
knockout efficiency.
The beneficial effect of extending the duplex generally
reached a peak at around 5 bp of added length (Fig. 2a).
To test whether extending the duplex by 5 bp is superior
to extending it by 4 bp or 6 bp, we extended the duplex
by 4 bp or 6 bp and compared the resulting knockout
efficiencies for the 16 sgRNAs in Fig. 3a. As shown in
Figure S8 in Additional file 1, extending the duplex by
4 bp or 6 bp appeared to yield similar knockout effi-
ciency as 5 bp in most cases.
Previously, Chen et al. [10] showed that mutating
T→A at position 4 in combination with extending the
duplex by 5 bp significantly enhanced the imaging effi-
ciency of the dCas9–GFP fusion protein in cells. Our
results showed that extending the duplex by 4–6 bp
and mutating T→C or G at position 4 significantly in-
creased knockout efficiency. To compare the effect of
two sgRNA designs on increasing the knockout effi-
ciency, we randomly selected ten sgRNAs targeting
CCR5 and compared their knockout efficiencies with
different mutations. As shown in Fig. 3c, all of the
T→C and most (nine out of ten) of the T→G muta-
tions had significantly higher knockout efficiency than
the T→A mutation. It is noteworthy that, although in
most cases the T→C mutation had a similar level of
knockout efficiency as the T→G mutation, it had a
significantly higher knockout efficiency in sp11
(+11 %, P = 0.006) and sp19 sgRNAs (+6 %, P = 0.026)
(Fig. 3c; Figure S9 in Additional file 1), suggesting that




































































































































Fig. 3 The optimized sgRNA structure is superior to the original version. a CCR5 knockout efficiency was determined for the indicated sgRNAs
targeting CCR5 with either an optimized sgRNA structure or the original structure. The knockout efficiency was determined in the same way as in
Fig. 1b. The raw data are sown in Figure S6 in Additional file 1. b CD4 knockout efficiency was determined for the indicated sgRNAs targeting the
CD4 gene, with two versions of the sgRNA structure in Jurkat cells. Cells were analyzed for CD4 expression by flow cytometry 72 hours after
transfection. The raw data are shown in Figure S7 in Additional file 1. c T→C and T→G mutations are superior to the T→A mutation. Eleven
sgRNAs targeting CCR5 were randomly selected. The knockout efficiency of sgRNAs with different mutations at position 4 in the sequence of
continuous Ts were determined as in Fig. 1c. The raw data are shown in Figure S9 in Additional file 1. The graphs represent biological repeats from
one of three independent experiments with similar results, shown as mean ± standard deviation (n = 3). Significance was calculated using
Student's t-test: *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001
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Creation of a frame-shift mutation with an sgRNA is
generally insufficient to investigate the loss of function
of noncoding genes, such as long noncoding RNAs
(lncRNAs) or microRNA genes. A better strategy is to
excise all or part of the gene of interest, which requires
cutting at two positions simultaneously and linking the
two breakpoints together. The efficiency of generating
this type of deletion mutation is very low with current
sgRNA design templates; however, the deletion effi-
ciency was improved dramatically (around tenfold) in
all four pairs of sgRNAs tested here (Fig. 4). If the ori-
ginal sgRNA structure, in which the deletion efficiency
ranged from 1.6–6.3 % (Fig. 2c), was used to delete tar-
get genes, one would have to screen hundreds of col-
onies to identify the colonies with the deletion, which is
a daunting task. Using the optimized sgRNAs, in which
the deletion efficiency ranged from 17.7–55.9 % (Fig. 4),
the number of colonies that would need to be screened
to identify those with the deletion would be within the
limits of feasibility. Thus, the optimized sgRNA tem-
plate would simplify the genome-editing procedure,
thereby enhancing its potential utility.
Mutating the contiguous Ts is likely to increase the pro-
duction of sgRNAs. Thus, to understand how modifications
increase the knockout efficiency, we measured the RNA
level of different sgRNA structures. First, we checked the
CCR5 knockout efficiency of the sgRNA with the extended
duplex or a mutated continuous sequence of Ts or with
both. Consistent with our previous study, both modifica-
tions individually increased knockout efficiency, and in
combination further increased knockout efficiency (Fig. 5a;
Figure S10 in Additional file 1). Next, we measured the
sgRNA levels in transfected cells. Mutating the continuous
sequence of Ts significantly increased the sgRNA level, and
it appears that extending the duplex also slightly increased
the sgRNA level (Fig. 5b). To ascertain if increased sgRNA
production or the sgRNA structure or both is responsible
for increased knockout efficacy, we transfected activated
CD4+ T cells with Cas9 protein preloaded with in vitro
transcribed sgRNAs, which excludes the effect of RNA level
change because in this case the amount of sgRNA remains
the same. In initial experiments, the results using the in
vitro transcribed sgRNAs were highly variable, because
these molecules form dimers to variable extents which in-
terfered with their functionality (Fig. 5c). Cas9 can only
bind to the monomers but not the dimers, in which the
sgRNA structure is not maintained. The ratio of monomers
to dimers was not fixed between samples, which led to











































































Fig. 4 The efficiency of gene deletion is increased dramatically using optimized sgRNAs. a The CCR5 gene deletion. b sgRNA pairs targeting CCR5
with the original or optimized structures were co-transfected into TZM-bl cells with a Cas9-expressing plasmid. The gene deletion efficiency was
determined by amplifying the CCR5 gene fragment. Note that the truncated fragments of CCR5, with a smaller size than wild-type CCR5, are a
consequence of gene deletion using paired sgRNAs. The numbers below each lane indicate the percentage deletion
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highly variable results. However, this problem was
solved by a heating and quick cooling step (Fig. 5c), as
we have previously shown for other small RNAs with
duplex structures [12]. With pure monomer sgRNAs, it
appeared that Cas9 preloaded with sgRNAs with an ex-
tended duplex has higher knockout efficiency (Fig. 5d;
Figure S11 in Additional file 1), suggesting that the
structural change of extending the duplex can by itself
increase Cas9 functionality. Next, we transfected in vitro
transcribed sgRNAs into cells stably expressing Cas9 and
showed that extending the duplex by itself increases knock-
out efficiency (Fig. 5e; Figure S11 in Additional file 1), most
likely because of the structural change and not because of
changes in RNA levels.
We performed all our experiments with transient plas-




































































































Fig. 5 How modifications increase knockout efficiency. a Knockout efficiency of sp3 from Fig. 2a with the indicated modifications was determined as
in Fig. 1b. The raw data are shown in Figure S10 in Additional file 1. Mut mutant, O original. b sgRNA levels were determined by real-time PCR. The relative
expression level was normalized to U6 small RNA. c In vitro transcribed sgRNA formed dimers (upper panel), which can be transformed into monomers by
a heating and quick cooling step (lower panel). d sp7 from Fig. 3b was transcribed in vitro and preloaded into Cas9. The complex was
electroporated into activated primary CD4+ T cells. Knockout efficiency was determined as in Fig. 3b. The raw data are shown in Figure S11 in
Additional file 1. e In vitro transcribed sp7 was electroporated into TZM-Cas9 cells. Knockout efficiency was determined as in Fig. 3b. The raw
data are shown in Figure S11 in Additional file 1. The graphs represent biological repeats from one of three independent experiments with similar
results, shown as mean ± standard deviation (n = 3). Significance was calculated using Student's t-test: *P < 0.05; **P < 0.01
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and the sgRNA can vary considerably. Low multiplicity
of infection (MOI) of lentivirus vector harboring the
Cas9 or the sgRNA should provide relatively consistent
copy numbers of Cas9 and sgRNA in infected cells.
Therefore, to determine sgRNA functionality more
rigorously, we first created cell lines stably expressing
Cas9 by infecting TZM-bl or JLTRG-R5 cells with lenti-
virus harboring a Cas9-expressing cassette and selecting
the cells stably expressing Cas9. We then infected these
cells with lentivirus harboring sgRNAs with different
structures at low MOI. The results were similar to the
experiments done with plasmids in both cell lines. In
fact, the difference between structures shown for lenti-
viral infection was even greater than what we observed
with plasmids (Fig. 6; Figure S12 in Additional file 1),
suggesting that the optimized sgRNAs are indeed superior
to commonly used sgRNA (+85 nucleotides). These re-
sults also suggest that the optimized sgRNAs would per-
form better for CRISPR-Cas9-based genome-wide pooled
screenings, which use lentivirus to deliver sgRNAs at low
MOI [13–20].
Discussion
In this study, we systematically investigated the effect of
extending the duplex and mutating the continuous se-
quence of Ts, providing guidance for optimizing sgRNA
structure. Our results clearly show that extending the
duplex and mutating the continuous sequence of Ts at
position 4 to C or G significantly increases knockout effi-
ciency in most cases, and the extent of the improvement
in knockout efficiency is striking (Figs. 3 and 4). The gen-
eral optimized sgRNA structure is illustrated in Fig. 7.
With the optimized structure, most sgRNAs showed
high knockout efficiency. Out of a total of 24 sgRNAs
with an optimized sgRNA structure tested, 18 showed
>50 % knockout efficiency. By contrast, only four sgRNAs
showed >50 % knockout efficiency using the original
sgRNA structure (Fig. 3a, b). This optimized sgRNA tem-
plate not only reduces concerns that knockout experiments
might not work due to low sgRNA functionality, but also
significantly increases the efficiency of more challenging
genome-editing procedures, such as gene deletion.
Previously, Hsu et al. [9] showed that extending the
duplex by 10 bp in combination with mutating the con-
tinuous sequence of Ts did not increase knockout effi-
ciency. Our results show that extending the duplex can
significantly increase knockout efficiency, but after
reaching a peak at around 5 bp, the effect declines,
which might explain this discrepancy. Our conclusion
is supported by Chen et al.’s study [10], in which they
showed that extending the duplex and mutating the
continuous sequence of Ts significantly enhances the
imaging efficiency of the dCas9–GFP fusion protein in
cells. The effects of these two modifications appear to
be different. Mutating the continuous sequence of Ts
significantly increased sgRNA production (Fig. 5b),
which is likely to be the result of increased transcrip-
tion efficiency due to the disrupted pause signal [11].
The results with in vitro transcribed sgRNAs suggest
that extending the duplex by itself also increases Cas9

















































Fig. 6 Testing the effect of modifications by lentiviral infection. TZM-bl cells (a) or JLTRG-R5 cells (b) were infected with Cas9-expressing lentivirus,
and cells stably expressing Cas9 were selected. The indicated sgRNA (sp3 from Fig. 2a)-expressing cassettes were packaged into lentivirus and
used to infect cells stably expressing Cas9 at MOI = 0.5. Knockout efficiency was determined as in Fig. 1b on the indicated days. The raw data are
shown in Figure S12 in Additional file 1. O original, Mut mutant
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since any effect of the RNA level was excluded in this ex-
periment. When sgRNA is expressed inside cells, both ef-
fects contribute to increase the functionality. It is
possible that the modified sgRNA structure might en-
hance binding to Cas9 or increase its stability. Further
work is needed to determine how exactly sgRNA struc-
ture increases functionality.
Conclusions
Extending the duplex by ~5 bp combined with mutating
the continuous sequence of Ts at position 4 to C or G sig-
nificantly increased CRISPR-Cas9 gene knockout efficiency.
Methods
Reagents
The TZM-bl cell line (catalog #8129) was obtained
from the NIH AIDS Reagent Program and cultured in
Dulbecco’s modified Eagle’s medium (DMEM; Life
Technologies) with high glucose. The Jurkat (E6-1) cell
line (catalog #177) was also obtained from the NIH
AIDS Reagent Program and cultured in RPMI medium
(Life Technologies). Both media were supplemented
with 10 % fetal bovine serum (Life Technologies) and
penicillin/streptomycin/L-glutamine (Life Technolo-
gies). All cells were maintained at 37 °C and 5 % CO2
in a humidified incubator.
Anti-CCR5 antibody (APC-conjugated, catalog #550856,
clone 3A9) was purchased from BD Biosciences. Anti-CD4
antibody (APC-conjugated, catalog #317416, clone OKT4)
was purchased from Biolegend. Anti-CD4 antibody (FITC-
conjugated, catalog #35-0049-T100, clone RPA-T4) was
purchased from TONBO Bioscience.
spCas9 protein was custom made (Novoprotein Scien-
tific) and stored at 1 mg/ml concentration in −80 °C.
Plasmid construction
sgRNA fragments were inserted into pLB vectors
(Addgene plasmid #11619) [21] at the Hpa I and Xho I
sites. Cloned pLB-sgRNA constructs were sequenced
to confirm that the sequence inserted was correct. The
oligo sequences are listed in Additional file 3. The
sgRNAs were started with either A or G, which is the
preferred initiation nucleic acid for the U6 promoter
[22]. Plasmids were purified with the EZNA Endo-free
Mini-prep kit (Omega Biotech). pSpCas9(BB) (pX330)
(catalog #42230) [4] and lentiCas9-Blast (catalog #52962)
[17] was purchased from Addgene. pX261-dU6 was
constructed from pX261-U6-DR-hEmx1-DR-Cbh-NLS-
hSpCas9-NLS-H1-shorttracr-PGK-puro (Addgene plas-
mid #42337) [4] by deleting a 398-bp fragment by NdeI
digestion, followed by Klenow reaction and blunt end
ligation to delete part of the U6 expression cassette.
Determining knockout efficiency
TZM-bl cells (9 × 104 per well) were seeded into 24-well
plates overnight before transfection and washed twice
with DPBS, and 300 μl of pre-warmed Opti-Mem I
medium was added to each well. pLB-sgRNA plasmids
(0.5 μg at a concentration of 0.1 μg/ul) were mixed with
0.5 μg of the Cas9 plasmid pX330 pre-mixed in 100 μl
of Opti-Mem I medium. Two microliters of Lipofecta-
mine 2000 transfection agent in 100 μl of Opti-Mem I
medium per well were added to the diluted plasmids,
followed by a 20-minute incubation. The complex was
added to the cells, and the medium was changed to
complete medium after a 6-hour incubation at 37 °C in
5 % CO2. Cells were collected for flow cytometry ana-
lysis 48 hours after transfection.
Jurkat cells were transfected with 0.5 μg of the pX330
plasmid and 0.5 μg of pLB-sgRNA constructs using the
Neon 10-μl transfection kit (Life Technologies), accord-
ing to the manufacturer’s instructions, and 2 × 105 cells
were used per 10-μl tip. Parameters were set to 1325 V,
10 ms, and three pulses. Cells were collected for flow cy-
tometry analysis 72 hours after transfection.
Cells were stained with either anti-CCR5 antibody for
TZM-bl cells or anti-CD4 antibody for Jurkat cells,
followed by analysis with a FACScanto II cell analyzer
(BD Bioscience). Only GFP-positive cells (GFP is a
marker expressed by the pLB vector, serving as positive
control for transfection) were analyzed for knockout
efficiency.
Determining the sgRNA expression level
TZM-bl cells (2.5 × 105 per well) were seeded into six-
well plates overnight before transfection. Cells were
transfected with 1.5 μg of pLB-sgRNA plasmids and
1.5 μg of the Cas9 plasmid pX330 with Lipofectamine
2000 (Life Technologies, catalog #11668019), according
to the manufacturer’s instructions. Cells were collected
48 hours after transfection. GFP-positive cells were
sorted with a FACSAria II cell sorter (BD Bioscience),
followed by small RNA extraction with the miRNeasy
Mini kit (Qiagen, catalog #217004). One microgram of ex-
tracted RNA was reverse transcribed with SuperScript® III
Reverse Transcriptase reaction (Life Technology, catalog
#18080-051), according to the manufacturer’s instructions.
The cDNAs were quantified with Syber Green qPCR Mas-
terMix (ABI, catalog #4309155) with primers (forward 5’-
Fig. 7 Optimized sgRNA structure. The duplex extension is
highlighted in red, and the mutation is marked in bold. The duplex
extension can be four to six nucleotides, and the mutation can be C
or G, which showed similar knockout efficiency in most cases
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GTGTTCATCTTTGGTTTTGTGTTT-3’ and reverse
5’-CGGTGCCACTTTTTCAAGTT-3’). U6B was used
as the internal control.
Evaluating target site modification at the DNA level by
next-generation sequencing
TZM-bl cells were transfected with Lipofectamine 2000 in
six-well plates, according to the manufacturer’s instructions.
Cells were collected 48 hours after transfection. GFP-
positive cells were sorted using a FACSAria II cell sorter
(BD Bioscience), followed by genomic DNA extraction
with the QIAamp DNA Blood Mini kit. CCR5 gene frag-
ments were amplified with the primers CCR5-DS-F (5’-
ACACTCTTTCCCTACACGACGCTCTTCCGATCTTC
TACCTGCTCAACCTGGCC-3’) and CCR5-DS-R (5’-
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCA
AGTCCCACTGGGCGGC-3’). The resulting PCR prod-
ucts were amplified for a second round of PCR with indi-
vidual index primers. The amplicons were run on a 2.5 %
agarose gel and purified with the QIAquick Gel Extraction
kit (QIAGEN, catalog #28704). Equal amounts of ampli-
cons were mixed and sequenced with a MiSeq sequencer
(Illumina).
Evaluating CCR5 disruption efficiency with lentiviral
delivery of sgRNA
Lenti-Cas9-Blast and the Viral Power packaging mix (Life
Technology, catalog #K4975-00) were co-transfected into
293 T cells with the calcium phosphate transfection proto-
col. Supernatant was collected and filtered through a 0.45-
μm filter before being used for infection of TZM-bl cells
and JLTRG-R5 cells (NIH AIDS Reagent Program #11586).
Cells (2 × 106) were seeded into a 10-cm dish. After over-
night culture, cells were infected with 1 ml viral super-
natant with 5 ng/ml polybrene for 3 hours. Forty-eight
hours after infection, the cells were treated with 10 μg/ml
blasticidin (Life Technology, catalog #R210-01) for 3 days.
The surviving cells were labeled as TZM-Cas9 or JLTRG-
R5-Cas9 cells.
pLB-sgRNAs were packaged into lentivirus in a similar
manner as Lenti-Cas9-Blast. TZM-Cas9 or JLTRG-R5-
Cas9 cells (1 × 105) were seeded into 24-well plates and in-
fected at MOI = 0.5. A portion of the cells were collected
at different time points and analyzed by FACS to deter-
mine the CCR5 disruption rate. The rate of occurrence of
GFP-positive cells was ~30 % for TZM-bl-Cas9 cells or
~10 % for JLTRG-R5-Cas9 cells.
Knockout of CD4 in primary CD4+ T cells with Cas9
preloaded with in vitro transcribed sgRNA
CD4+ T cells were isolated from peripheral blood mono-
nuclear cells with StemSep™ Human CD4+ T Cell Enrich-
ment Kit (StemCell Technologies, catalog #14052), and
activated with Dynabeads® Human T-Activator CD3/CD28
(Life Technology, catalog #11131D) for 5 days in the
presence of 20 U/ml IL-2 (NIH AIDS Reagents Program,
catalog #136), 10 % fetal calf serum, and 1× penicillin-
streptomycin-glutamine solution (Life Technology, catalog
#10378-016).
sgRNAs were transcribed with HiScribe T7High Yield
RNA Synthesis kit (NEB) according to the manufacturer’s
instructions, followed by purification with the RNeasy
Mini kit (Qiagen, catalog #217004). Before each use,
sgRNAs were heated to 95 °C for 3 minutes in a PCR tube
and immediately transferred to a water/ice bath for 2 mi-
nutes to obtain pure monomers.
Activated primary CD4+ T cells were electroporated
using the Neon transfection system (100 μl tip, Life
Technologies, catalog #MPK10096) with 10 μg of
spCas9 protein that was preloaded with 300 pmol
sgRNA (mixed and incubated at room temperature for
10 minutes). Cells (1 × 106) resuspended in 100 μl R
buffer were mixed with a protein:RNA mix, followed by
Neon electroporation (1500 V, 10 ms, three pulses), ac-
cording to the manufacturer’s instructions. After
48 hours, the cells were stained with CD4 antibody and
subjected to FACS analysis.
TZM-Cas9 cells were electroporated by Neon trans-
fection system (10 μl tip; Life Technology catalog
#MPK1096) with 30 pmol sgRNA. Cells (5 × 104) were
re-suspended in 10 μl R buffer and mixed with RNA,
followed by Neon electroporation (1005 V, 35 ms, two
pulses) according to the manufacturer’s instructions.
After 48 hours, the cells were stained with CD4 antibody
and subject to FACS analysis.
Gene deletion assay
TZM-bl cells were co-transfected with sgRNA pairs
(0.25 μg each) along with 0.5 μg of the Cas9-expressing
plasmid pX261-dU6.sgRNA: pair 1 was CCR5 sp7 plus
sp14; pair 2 was CCR5 sp7 plus sp18; pair 3 was CCR5
sp10 plus sp14; and pair 4 was CR5 sp10 plus sp18. The
sgRNA sequences are provided in Additional file 3.
Twenty-four hours after transfection, the cells were
treated with 0.8 μg/ml puromycin for 48 hours, followed
by recovery in medium without puromycin for 5 days.
Genomic DNA was extracted from cells with the GenE-
lute™ Mammalian Genomic DNA Miniprep kit (Sigma-
Aldrich, catalog #G1N70). CCR5 gene fragments were
amplified from 70 μg of genomic DNA using Premix Ex
Taq (Takara, catalog #RR003A) with forward primer 5’-
ATGGATTATCAAGTGTCAAGTCCAA-3’ and reverse
primer 5’-AGGGAGCCCAGAAGAGAAAATAAAC-3’
for the CCR5 gene. The PCR was stopped at different
cycle numbers to check the amount of amplicon and en-
sure that the amplification was in the exponential phase.
PCR amplicons were analyzed on a 1 % agarose gel.
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Statistical analysis
Student’s t-test (two-tailed, assuming equal variances for
all experimental data sets) was used to compare two
groups of independent samples.
Data availability
The data set supporting the results of Fig. 1b in this article




Additional file 1: Figure S1. a Native crRNA-tracrRNA duplex. b Short
sgRNA (+48 nucleotides). c Commonly used lone sgRNA (+85 nucleotides).
Figure S2. CCR5 knockout efficiency as determined by flow cytometry for
the sgRNAs in Fig. 1b, c. Figure S3. CCR5 knockout efficiency as determined
by flow cytometry for the sgRNAs in Fig. 1d. Figure S4. CCR5 knockout
efficiency as determined by flow cytometry for the sgRNAs in Fig. 2a.
Figure S5. CCR5 knockout efficiency as determined by flow cytometry for
the sgRNAs in Fig. 2b. Figure S6. CCR5 knockout efficiency as determined
by flow cytometry for the sgRNAs in Fig. 3a. Figure S7. CD4 knockout
efficiency as determined by flow cytometry for the sgRNAs in Fig. 3b.
Figure S8. CCR5 knockout efficiency for the indicated sgRNAs with a 4-, 5-,
or 6-bp duplex extension. CCR5 expression was determined in the same
way as in Fig. 1b. Figure S9. CCR5 knockout efficiency for the indicated
sgRNAs with T→A, T→C and T→G mutations for the sgRNAs in Fig. 3c.
Figure S10. CCR5 knockout efficiency as determined by flow cytometry for
the sgRNAs in Fig. 5a. Figure S11. CD4 knockout efficiency as determined
by flow cytometry for the sgRNAs in Fig. 5d, e. Figure S12. CCR5 knockout
efficiency as determined by flow cytometry for the sgRNAs in Fig. 6.
(PDF 2487 kb)
Additional file 2: Dataset S1. Deep sequencing raw data of CCR5
target site modification of Fig. 2b. (XLSX 236 kb)
Additional file 3: Table S1. sgRNA sequences. (XLSX 14 kb)
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